GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.05 (-3.54%)
Close on Nov 17, 2026Market cap $2.95MP/E –Yield –
GRI Bio total assets
Total assets on the balance sheet at the end of each period.
GRI Bio's total assets was $11.38M at Jun 30, 2026. For fiscal 2025 it was $8.67M, up 51.0% from the year before. The highest annual figure on record is $8.67M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.67M | +51.0% |
| FY2024 | Dec 31, 2024 | $5.74M | +94.1% |
| FY2023 | Dec 31, 2023 | $2.96M | +671.8% |
| FY2022 | Dec 31, 2022 | $383.00K | -95.4% |
| FY2021 | Dec 31, 2021 | $8.34M | +772.8% |
| FY2020 | Dec 31, 2020 | $955.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.38M | +100.5% |
| Q1 FY2026 | Mar 31, 2026 | $11.34M | +180.5% |
| Q4 FY2025 | Dec 31, 2025 | $8.67M | +51.0% |
| Q3 FY2025 | Sep 30, 2025 | $4.78M | -12.4% |
| Q2 FY2025 | Jun 30, 2025 | $5.68M | -19.3% |
| Q1 FY2025 | Mar 31, 2025 | $4.04M | -11.9% |
| Q4 FY2024 | Dec 31, 2024 | $5.74M | +94.1% |
| Q3 FY2024 | Sep 30, 2024 | $5.46M | +24.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.03M | +24.6% |
| Q1 FY2024 | Mar 31, 2024 | $4.59M | +118.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.96M | +671.8% |
| Q3 FY2023 | Sep 30, 2023 | $4.40M | -20.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.64M | -29.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.10M | -64.7% |
| Q4 FY2022 | Dec 31, 2022 | $383.00K | -95.4% |
| Q3 FY2022 | Sep 30, 2022 | $5.57M | -45.1% |
| Q2 FY2022 | Jun 30, 2022 | $8.01M | -31.3% |
| Q1 FY2022 | Mar 31, 2022 | $5.94M | -59.3% |
| Q4 FY2021 | Dec 31, 2021 | $8.34M | +772.8% |
| Q3 FY2021 | Sep 30, 2021 | $10.14M | – |
| Q2 FY2021 | Jun 30, 2021 | $11.65M | – |
| Q1 FY2021 | Mar 31, 2021 | $14.60M | – |
| Q4 FY2020 | Dec 31, 2020 | $955.00K | – |
See a number that looks wrong?